---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-031128"
form_type: "8-K"
ticker: "PYXS"
cik: "0001782223"
company_name: "Pyxis Oncology, Inc."
filed_at: "2023-06-30T23:59:59+00:00"
generated_at: "2026-06-13T14:13:33.377254+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Pyxis Oncology expands board to 7, appoints Dr. Jakob Dupont as director contingent on Apexigen merger

## Summary
- Board size increased to seven members, effective upon closing of merger with Apexigen.
- Dr. Jakob Dupont appointed as Class III director, term expiring at 2024 annual meeting.
- Dr. Dupont executed voting agreement to support merger proposals; no other arrangements or family ties.
- Appointment contingent on merger completion; Dr. Dupont eligible for non-employee director compensation.

## SEC filing metadata
- accession: 0000950170-23-031128
- form_type: 8-K
- ticker: PYXS
- cik: 0001782223
- company_name: Pyxis Oncology, Inc.
- filed_at: 2023-06-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782223/000095017023031128/0000950170-23-031128-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782223/000095017023031128/pyxs-20230628.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-031128
- JSON: https://secwatch.observer/filing/0000950170-23-031128.json
- Plain text: https://secwatch.observer/filing/0000950170-23-031128.txt

## Key facts
- Executive change
  Jakob Dupont was appointed as Director at Pyxis Oncology, Inc..
  - Action: appointed
  - Role: Director
  source text: the Board also approved on a prospective basis the appointment of Jakob Dupont, M.D. as a director of the Company to fill the vacancy created by that action.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1782223/000095017023031128/0000950170-23-031128-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.